Views

CrossRef citations to date

Altmetric

Research Paper

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

Thomas L. Richie Naval Medical Research Center; Silver Spring, MD USACorrespondence[email protected]

Yupin Charoenvit Naval Medical Research Center; Silver Spring, MD USA

Ruobing Wang Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Judith E. Epstein Naval Medical Research Center; Silver Spring, MD USA

Richard C. Hedstrom Naval Medical Research Center; Silver Spring, MD USA

Sanjai Kumar Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Thomas C. Luke Naval Medical Research Center; Silver Spring, MD USA

Daniel A. Freilich Naval Medical Research Center; Silver Spring, MD USA

Joao C. Aguiar Pan American Health Organization; Washington, DC USA

John B. Sacci, Jr. Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Martha Sedegah Naval Medical Research Center; Silver Spring, MD USA

Ronald A. Nosek, Jr. Naval Medical Research Center; Bethesda, MD USA

Patricia De La Vega Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Mara P. Berzins Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Victoria F. Majam Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Esteban N. Abot Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Harini Ganeshan Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Nancy O. Richie Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Jo Glenna Banania Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Maria Fe B. Baraceros Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Tanya G. Geter Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Robin Mere Vical; San Diego, CA USA

Lolita Bebris Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Keith Limbach Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

Bradley W. Hickey Naval Medical Research Center; Silver Spring, MD USA

David E. Lanar Walter Reed Army Institute of Research; Silver Spring, MD USA

Jennifer Ng C.W. Bill Young Department of Defense Marrow Donor Program; Rockville, MD USA

Meng Shi Walter Reed Army Institute of Research; Silver Spring, MD USA

Peter M. Hobart Vical; San Diego, CA USA

Jon A. Norman Vical; San Diego, CA USA

Lorraine A. Soisson USAID; Washington, DC USA

Michael R. Hollingdale Naval Medical Research Center; Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine; Bethesda, MD USA

William O. Rogers Naval Medical Research Center; Silver Spring, MD USA

Denise L. Doolan Naval Medical Research Center; Silver Spring, MD USA

Stephen L. Hoffman Naval Medical Research Center; Silver Spring, MD USA

show all

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

Additional material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

Additional material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date